New Chicago-area plant for Germany's Vetter promises 300 jobs

Vetter to build production facility in Chicago area.

Vetter, a German company that specializes in contract aseptic filling, said it will build a production facility in the Chicago suburb of Des Plaines, IL. 

It’s expected that the facility will create about 300 jobs, and the company plans to eventually build up to 1 million square feet of space on the 17-acre site that used to be home to the Salvation Army’s central territory headquarters.

Details of the agreement between the Ravensburg, Germany-based CDMO and the state’s Department of Commerce and Economic Opportunity didn’t outline specific incentives given to Vetter as part of the deal, the Chicago Tribune reported.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Still, the state said Vetter, which already has a production operation and offices in Skokie, plans to invest $320 million in the facility. 

Vetter, which is privately held, specializes in filling syringes and vials with liquid medicines in sterile environments. One of the company's customers is AbbVie ($ABBV), the seller of arthritis fighter Humira, the world's best-selling prescription drug. In addition to AbbVie, other big pharma companies based in Chicago’s northern suburbs include Abbott ($ABT) and Baxter ($BAX).

- here’s the release
- check out the Tribune story

Related Article:
Vetter putting $100M into its production network


Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.